Regal Partners Ltd Increases Stock Position in Core Scientific, Inc. (NASDAQ:CORZ)

Regal Partners Ltd increased its position in Core Scientific, Inc. (NASDAQ:CORZ) by 71.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 996,551 shares of the company’s stock after purchasing an additional 415,363 shares during the quarter. Core Scientific accounts for 1.0% of Regal Partners Ltd’s portfolio, making the stock its 27th largest position. Regal Partners Ltd owned 0.39% of Core Scientific worth $11,819,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in CORZ. ORG Wealth Partners LLC purchased a new position in shares of Core Scientific in the third quarter valued at $106,266,000. Vanguard Group Inc. purchased a new position in shares of Core Scientific in the first quarter valued at $21,973,000. Kensico Capital Management Corp purchased a new position in shares of Core Scientific in the first quarter valued at $18,513,000. Van ECK Associates Corp acquired a new position in Core Scientific during the 2nd quarter valued at about $12,239,000. Finally, Vident Advisory LLC acquired a new position in Core Scientific during the 1st quarter valued at about $4,047,000.

Insider Buying and Selling

In other news, Director Jarrod M. Patten acquired 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was acquired at an average cost of $9.70 per share, for a total transaction of $38,800.00. Following the completion of the acquisition, the director now owns 279,239 shares in the company, valued at approximately $2,708,618.30. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Jarrod M. Patten acquired 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was acquired at an average cost of $9.70 per share, for a total transaction of $38,800.00. Following the completion of the acquisition, the director now owns 279,239 shares in the company, valued at approximately $2,708,618.30. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares in the company, valued at approximately $1,150,061.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders bought 12,761 shares of company stock worth $127,080. Corporate insiders own 32.00% of the company’s stock.

Core Scientific Trading Down 5.5 %

Shares of NASDAQ:CORZ opened at $16.13 on Thursday. Core Scientific, Inc. has a 1 year low of $2.61 and a 1 year high of $18.03. The business has a fifty day simple moving average of $12.76 and a 200 day simple moving average of $9.72. The firm has a market cap of $4.50 billion and a price-to-earnings ratio of -2.98.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CORZ shares. Canaccord Genuity Group started coverage on shares of Core Scientific in a research note on Monday, September 23rd. They set a “buy” rating and a $16.00 target price on the stock. Needham & Company LLC raised their target price on shares of Core Scientific from $17.00 to $18.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. HC Wainwright raised their price objective on shares of Core Scientific from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Macquarie began coverage on shares of Core Scientific in a research report on Wednesday, September 25th. They set an “outperform” rating and a $16.00 price objective on the stock. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $17.00 target price on shares of Core Scientific in a report on Thursday, November 7th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $17.21.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.